A. RAHAG
Abstract
A patient with severe Guillain-Barré syndrome responded to treatment with high-dose intravenous immunoglobulins. It is suggested, on the basis of recent case reports, that immunoglobulins may have an important rôle in the future treatment of this immune-mediated disease.
OpenAlex reports 5 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
A patient with severe Guillain-Barré syndrome responded to treatment with high-dose intravenous immunoglobulins. It is suggested, on the basis of recent case reports, that immunoglobulins may have an important rôle in the future treatment of this immune-mediated disease.
Key concepts: Medicine, Intravenous Immunoglobulins, Guillain-Barre syndrome, Antibody, Disease, Immune system, Immunology, Internal medicine